Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study

Background: Understanding the burden of COVID-19 infection in pediatric populations is crucial for guiding public health interventions and policies. However, there are few age-stratified data available on COVID-19 infection in children, including in Uganda. This study describes the seroprevalence of SARS-CoV-2 and risk factors for infection among children across Uganda at two survey timepoints. In addition, data are reported on COVID-19 related knowledge, attitudes, and practices from Ugandan households, including adult vaccination status. Methods: Baseline cross-sectional community surveys were carried out in 12 communities from April to May 2021 (post-Alpha wave), followed by surveys in 32 communities from November 2021 to March 2022 during the Omicron wave. A household questionnaire was administered and blood samples were collected to assay for presence of malaria parasites by microscopy and SARS-CoV-2 seropositivity using a Luminex assay. Seroprevalence was estimated at the survey and community level. Mixed-effects logistic regression models measured associations between individual and household-level factors with SARS-CoV-2 seropositivity among children, adjusting for household clustering. Results: More households reported disruptions in daily life at baseline compared to follow-up, though economic impacts lingered. By the follow-up survey, 52.7% of eligible adults had received at least one COVID-19 vaccine dose. Overall adjusted seroprevalence in children was higher at follow-up compared to baseline (71.6% versus 19.2%, p < 0.001). Seroprevalence in children ranged across communities from 6-37% in the baseline survey and 50-90% in the follow-up survey. At baseline, children from the poorest households were more likely to be infected. Increasing age remained the only consistent risk factor for SARS-CoV-2 seroconversion at both timepoints. Conclusions: Results indicate that a larger number of children were infected during the Delta and Omicron waves of COVID-19 compared to the Alpha wave. This study is the largest seroprevalence survey in children in Uganda, providing evidence that most children were infected with SARS-CoV-2 before the vaccine was widely available to pediatric populations. Pediatric infections were vastly underreported by case counts, highlighting the importance of seroprevalence surveys in assessing disease burden when testing and reporting rates are limited and many cases are mild or asymptomatic.

[1]  M. Kibria,et al.  Estimating the effects of COVID-19 on essential health services utilization in Uganda and Bangladesh using data from routine health information systems , 2023, Frontiers in public health.

[2]  Charles Kabugo,et al.  Effect of COVID-19 pandemic on inpatient service utilization and patient outcomes in Uganda , 2023, Scientific reports.

[3]  O. Laeyendecker,et al.  SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022 , 2023, Transfusion.

[4]  T. Bousema,et al.  Measures of malaria transmission, infection, and disease in an area bordering two districts with and without sustained indoor residual spraying of insecticide in Uganda , 2022, PloS one.

[5]  P. Hotez,et al.  SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis , 2022, eClinicalMedicine.

[6]  C. Troeger,et al.  Interventions for Maintenance of Essential Health Service Delivery during the COVID-19 Response in Uganda, between March 2020 and April 2021 , 2022, International journal of environmental research and public health.

[7]  L. Podewils,et al.  Epidemiology and Transmission Dynamics of COVID-19 in an Urban Pediatric US Population , 2022, Public health reports.

[8]  A. Kirubarajan,et al.  Socioeconomic and immigration status and COVID-19 testing in Toronto, Ontario: retrospective cross-sectional study , 2022, BMC Public Health.

[9]  C. John,et al.  Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection , 2022, medRxiv.

[10]  S. Teichmann,et al.  Local and systemic responses to SARS-CoV-2 infection in children and adults , 2021, Nature.

[11]  G. Dorsey,et al.  Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis , 2021, Malaria journal.

[12]  R. Wanyenze,et al.  Unintended socio-economic and health consequences of COVID-19 among slum dwellers in Kampala, Uganda , 2021, BMC Public Health.

[13]  A. Kaminga,et al.  Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis , 2021, Reviews in medical virology.

[14]  J. Nkengasong,et al.  Understanding COVID-19 in Africa , 2021, Nature Reviews Immunology.

[15]  A. Josephson,et al.  Socioeconomic impacts of COVID-19 in low-income countries , 2021, Nature Human Behaviour.

[16]  J. Nkengasong,et al.  The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study , 2021, The Lancet.

[17]  12,et al.  SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay , 2021, medRxiv.

[18]  Manish M Patel,et al.  Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years — Mississippi, September–November 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[19]  E. Hod,et al.  Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum , 2020, Nature Immunology.

[20]  R. Viner,et al.  Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. , 2020, JAMA pediatrics.

[21]  Jiahui Li,et al.  Comparative Analysis of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children. , 2020, Annals of the Academy of Medicine, Singapore.

[22]  Otto O. Yang,et al.  Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 , 2020, The New England journal of medicine.

[23]  J. Nkengasong,et al.  COVID-19 in Africa: the spread and response , 2020, Nature Medicine.

[24]  A. Flahault,et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.

[25]  Wenjun Liu,et al.  COVID‐19 epidemic: Disease characteristics in children , 2020, Journal of medical virology.

[26]  J. Ludvigsson Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.

[27]  G. Wong,et al.  SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.

[28]  C. Drakeley,et al.  Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. , 2019, Wellcome open research.

[29]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[30]  Megan Holstein,et al.  Website , 2019, iPhone App Design for Entrepreneurs.